Literature DB >> 22315255

Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Gordon H Guyatt1, Elie A Akl2, Mark Crowther3, Holger J Schünemann4, David D Gutterman5, Sandra Zelman Lewis6.   

Abstract

The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially from the prior versions both in process and in content. In this introduction, we describe some of the differences and the rationale for the changes.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22315255      PMCID： PMC3278068          DOI： 10.1378/chest.11-2286

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  19 in total

1.  Clinical experts or methodologists to write clinical guidelines?

Authors:  Jack Hirsh; Gordon Guyatt
Journal:  Lancet       Date:  2009-04-23       Impact factor: 79.321

2.  The wizard of WOS -- or the art of the task force.

Authors:  Renaldo N Battista
Journal:  J Clin Epidemiol       Date:  2009-04-08       Impact factor: 6.437

3.  Going from evidence to recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Yngve Falck-Ytter; Gunn E Vist; Alessandro Liberati; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-10

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  An official American Thoracic Society Policy statement: managing conflict of interest in professional societies.

Authors:  Holger J Schünemann; Molly Osborne; Joel Moss; Constantine Manthous; Gregory Wagner; Leonard Sicilian; Jill Ohar; Shane McDermott; Lance Lucas; Roman Jaeschke
Journal:  Am J Respir Crit Care Med       Date:  2009-09-15       Impact factor: 21.405

Review 6.  What is "quality of evidence" and why is it important to clinicians?

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Gunn E Vist; Yngve Falck-Ytter; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-03

7.  Grades of recommendation for antithrombotic agents.

Authors:  G Guyatt; H Schunëmann; D Cook; R Jaeschke; S Pauker; H Bucher
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

8.  ACCP-NHLBI National Conference on Antithrombotic Therapy. American College of Chest Physicians and the National Heart, Lung and Blood Institute.

Authors: 
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

9.  Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Gordon H Guyatt; Deborah J Cook; Roman Jaeschke; Stephen G Pauker; Holger J Schünemann
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Sam Schulman; Rebecca J Beyth; Clive Kearon; Mark N Levine
Journal:  Chest       Date:  2008-06       Impact factor: 9.410
View more
  43 in total

1.  Pharmacogenetic testing: Current Evidence of Clinical Utility.

Authors:  Jivan Moaddeb; Susanne B Haga
Journal:  Ther Adv Drug Saf       Date:  2013-08-01

2.  Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Susan L Norris; Sam Schulman; Jack Hirsh; Mark H Eckman; Elie A Akl; Mark Crowther; Per Olav Vandvik; John W Eikelboom; Marian S McDonagh; Sandra Zelman Lewis; David D Gutterman; Deborah J Cook; Holger J Schünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  New onset S wave in pulmonary embolism: revisited (something old and something new).

Authors:  Prabha Nini Gupta; Siju B Pillai; Sajan Z Ahmad; Shifas M Babu
Journal:  BMJ Case Rep       Date:  2013-11-25

Review 4.  Conflicts of interest disclosure forms and management in critical care clinical practice guidelines.

Authors:  Waleed Alhazzani; Kimberley Lewis; Roman Jaeschke; Bram Rochwerg; Morten Hylander Møller; Laura Evans; Kevin C Wilson; Sheena Patel; Craig M Coopersmith; Maurizio Cecconi; Gordon Guyatt; Elie A Akl
Journal:  Intensive Care Med       Date:  2018-09-27       Impact factor: 17.440

5.  Inhospital mortality among clinical and surgical inpatients recently diagnosed with venous thromboembolic disease.

Authors:  María Lourdes Posadas-Martínez; Fernando Javier Vázquez; María Florencia Grande-Ratti; Fernán González Bernaldo de Quirós; Diego Hernán Giunta
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

Review 6.  Peri-procedural management of anti-platelets and anticoagulation in patients undergoing MitraClip procedure.

Authors:  Said Alsidawi; Mohamad Effat
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

7.  Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis.

Authors:  Claudio Cimminiello; Paolo Prandoni; Giancarlo Agnelli; Giovanni Di Minno; Hernan Polo Friz; Francesco Scaglione; Patrizia Boracchi; Giuseppe Marano; Job Harenberg
Journal:  Intern Emerg Med       Date:  2017-07-29       Impact factor: 3.397

8.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

9.  Continuation of venous thromboembolism prophylaxis after hospital discharge into the outpatient setting: the ACCEPT study.

Authors:  Sebastian M Schellong; Jürgen Kaiser; Peter Bramlage
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

10.  Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.

Authors:  Alexander Zarbock; Mira Küllmar; Detlef Kindgen-Milles; Carola Wempe; Joachim Gerss; Timo Brandenburger; Thomas Dimski; Bartosz Tyczynski; Michael Jahn; Nils Mülling; Martin Mehrländer; Peter Rosenberger; Gernot Marx; Tim Philipp Simon; Ulrich Jaschinski; Philipp Deetjen; Christian Putensen; Jens-Christian Schewe; Stefan Kluge; Dominik Jarczak; Torsten Slowinski; Marc Bodenstein; Patrick Meybohm; Stefan Wirtz; Onnen Moerer; Andreas Kortgen; Philipp Simon; Sean M Bagshaw; John A Kellum; Melanie Meersch
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.